Business
Why Alterity Therapeutics (ASX:ATH) share price has surged up 27% today // Motley Fool Australia
The Alterity Therapeutics Ltd (ASX: ATH) share price has rocketed up 27% this morning after its patent was approved by the United States Patent and Trademark Office. At the time of writing, the Alterity share price is trading up at 3.3 cents.
Approval of US patent
The new patent is the result of Alterity’s in-house discovery research and is central to its next generation drug development portfolio focused on neurodegenerative diseases.
Alterity’s lead product, ATH434, is showing potential to treat various forms of atypical Parkinsonism. Parkinsonian disorders are a group of diseases in which individuals experience slowness of movement, stiffness and tremor. They include Parkinson’s disease and Multiple System Atrophy, as…
-
Noosa News23 hours agoBrisbane kindergarten thrown into chaos amid bitter dispute
-
Noosa News23 hours agoNew Farm aged care facility to make way for luxury apartments
-
General24 hours agoSouth Korean woman who bit attacker’s tongue off has 1964 conviction quashed
-
Noosa News11 hours agoMan shot by police outside Wynnum West house fire charged with attempted murder and arson